InvestorsHub Logo
Followers 15
Posts 4090
Boards Moderated 0
Alias Born 06/10/2001

Re: None

Monday, 09/09/2013 9:55:56 AM

Monday, September 09, 2013 9:55:56 AM

Post# of 16750
Here's what i like from today's PR:

"The data from these two Phase I studies provides strong evidence of ThermoDox's broad potential clinical value across different cancers, including the ability to provide a new tool against aggressive, superficial tumors. We look forward to rapidly recruiting patients for the Phase 2 portion of the DIGNITY Study."